Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
-502K
-
Total reported value, excl. options
-
$38.6M
-
Value change
-
-$1.64M
-
Put/Call ratio
-
9.75
-
Number of buys
-
19
-
Number of sells
-
-41
-
Price
-
$2.15
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q2 2023
82 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q2 2023.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 66M outstanding shares and own 27.17% of the company stock.
Largest 10 shareholders include CANNELL CAPITAL LLC (2.77M shares), Archon Capital Management LLC (2.45M shares), VANGUARD GROUP INC (1.35M shares), Balyasny Asset Management L.P. (1.3M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (1.13M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (945K shares), Kent Lake Capital LLC (706K shares), First Eagle Investment Management, LLC (580K shares), Brandywine Global Investment Management, LLC (502K shares), and First Washington CORP (496K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.